Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2017

01-04-2017 | Letter to the Editor

Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia

Authors: Laura Orioli, K. Sarti, E. Van Den Neste, D. Maiter

Published in: Annals of Hematology | Issue 4/2017

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Fain JS, Naeim F, Becker DP, Van Herle A, Yan-Go F, Petrus L, Vinters HV (1992) Chronic lymphocytic leukemia presenting as a pituitary mass lesion. Can J Neurol Sci 19:239–242PubMed
2.
Owen C, Assouline S, Kuruvilla J, Uchida C, Bellingham C, Sehn L (2015) Novel therapies for chronic lymphocytic leukemia: a Canadian perspective. Clin Lymphoma Myeloma Leuk 15:627–634CrossRefPubMed
3.
Lodish MB, Stratakis CA (2010) Endocrine side effects of broad-acting kinase inhibitors. Endocr Relat Cancer 17:233–244CrossRef
4.
Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV (2016) Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin Endocrinol 85:331–339CrossRef
5.
Bilgir O, Kebapcilar L, Bilgir F, Sarì I, Oner P, Karaca B, Alacacioglu I (2010) Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction? Int J Clin Pract 64:45–50CrossRefPubMed
Metadata
Title
Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia
Authors
Laura Orioli
K. Sarti
E. Van Den Neste
D. Maiter
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-2928-7

Other articles of this Issue 4/2017

Annals of Hematology 4/2017 Go to the issue

Original Article

Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial

Review Article

Primary myelofibrosis and its targeted therapy

Original Article

Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy

Letter to the Editor

Vaccination of allogeneic hematopoietic stem cell transplant recipients—what should be considered?

Original Article

The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry

Original Article

Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits